Differentiation Syndrome in a Patient With NSCLC Harboring IDH2 Mutation Treated With Enasidenib: Case Report

Authors: Bhoomika Sukhadia, MD, Dean Tan, BA, BS, Youjin Oh, MD, Zunairah Shah, MD, Young Kwang Chae, MD, MPH, MBA

Source: JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100520- (2024)

Subject Terms: Enasidenib, IDH2 inhibitor, Differentiation syndrome, Non–small cell lung cancer, Case Report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323000590; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/19831a8ca6a14d10bc58dd48f0004a12